COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04764981


Column Value
Trial registration number NCT04764981
Full text link
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

ALNA CAROLINA MENDES PARANHOS

Contact
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Not reported

Registration date
Last imported at : Feb. 24, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

2021-02-21

Recruitment status
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Recruiting

Study design
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Long covid

Inclusion criteria
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

inclusion criteria: - confirmed diagnosis of covid-19 by real time polymerase chain-reaction for sars-cov-2 or serological tests for sars-cov-2 antigens.\ - olfactory dysfunction confirmed by connecticut chemosensory clinical research test (cccrc-t).

Exclusion criteria
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

- smokers - individuals with diagnosed rhinitis - individuals with diagnosed neurological diseases - individuals submitted to brain surgery - previous historic of hyposmia and/ or anosmia - pregnancy - allergy to any of the substances present in the olfactory test kit - individuals who are undergoing another treatment for olfactory dysfunction

Number of arms
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Universidade do Estado do ParĂ¡

Inclusion age min
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

65

Countries
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Brazil

Type of patients
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

Patients recovered from covid

Severity scale
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

350

primary outcome
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

To Assess the effectiveness of olfactory training therapy in the treatment of persistent olfactory dysfunctions after COVID-19

Notes
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : Feb. 23, 2021, 12:31 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 477, "treatment_name": "Essence oils", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "Additional control group (50 participants) of without previous COVID-19 infection not presented", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]